Evaldo laboratorija - Company finances
|
EUR
|
2020
From: 2020-01-23
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|
|
Financial data
|
||||||
| Sales revenue | 23,921 | 94,172 | 90,900 | 94,131 | 88,522 | 75,577 |
| Profit before tax | - | - | - | - | - | 23,566 |
| Net profit | -5,976 | 47,307 | 30,191 | 32,992 | 38,761 | 21,966 |
| Equity | -3,476 | 43,831 | 25,786 | 18,894 | 15,302 | 16,670 |
| Liabilities | 21,096 | 5,323 | 35,166 | 30,616 | 27,413 | 18,575 |
| Non-current assets | 6,730 | 10,935 | 41,128 | 30,815 | 22,566 | 19,042 |
| Current assets | 8,806 | 38,122 | 18,783 | 18,638 | 19,018 | 15,967 |
| Total assets | 15,536 | 49,057 | 59,911 | 49,453 | 41,584 | 35,009 |
|
Taxes paid
|
||||||
| STI taxes | - | - | - | 10,514 | 7,098 | 9,436 |
|
Financial indicators
|
||||||
| Revenue change y/y | - | +293.7% | -3.5% | +3.6% | -6.0% | -14.6% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | -38.5% | 96.4% | 50.4% | 66.7% | 93.2% | 62.7% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | - | 107.9% | 117.1% | 174.6% | 253.3% | 131.8% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | -25.0% | 50.2% | 33.2% | 35.0% | 43.8% | 29.1% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | - | - | - | - | 31.2% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | 0.1 | 1.4 | 1.6 | 1.8 | 1.1 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 23,921 | 94,172 | 90,900 | 94,131 | 88,522 | 75,577 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Evaldo laboratorija - Social security debts
The company had no debts to Sodra
Evaldo laboratorija - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Evaldo laboratorija, UAB (code 305438258) is a Private Limited Liability Company engaged in the manufacture of prosthetic appliances, implants and orthodontic devices. In 2025, the company generated revenue of €75.6K and net profit of €22.0K, giving a profit margin of 29.1%. Revenue declined by 14.6% year on year and by 19.7% over two years, indicating a weaker top-line trend after €94.1K in 2023 and €88.5K in 2024. Profitability remained positive throughout the period, with net profit of €33.0K in 2023, €38.8K in 2024 and €22.0K in 2025; 2024 was the strongest profit year despite lower revenue. At the end of 2025, total assets stood at €35.0K, equity at €16.7K and liabilities at €18.6K. The equity ratio was 47.6% and debt-to-equity was 1.11, suggesting a balanced capital structure. Asset turnover reached 2.16x, while revenue per employee was €75.6K and profit per employee €22.0K. Return indicators were strong, although they were supported by a relatively small equity base.